Építés alatt – nem éles oldal
Belépés

Diffúz nagy B-sejtes limfóma (DLBCL) trials, also abroad

383 open Diffúz nagy B-sejtes limfóma (DLBCL) trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Kína134
Egyesült Államok133
Olaszország35
Franciaország27
Spanyolország25
All other countries

The same trial often runs in several countries

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003) has 1 site in Új-Zéland and runs in 26 countries. If a site near you is full, another one may still take people.

See A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003) in all 26 countries
Építés alatt, nem éles – Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Új-Zéland – Frontlight Research